ArticleACS infectious diseases2021

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.

Kas Steuten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.